港股荣昌生物（09995）今日盘中大涨5%，引发市场关注。此次涨势与港股生物医药板块整体走强密切相关。
据悉，今日港股创新药板块表现活跃，多只相关股票出现明显上涨。除荣昌生物外，再鼎医药涨超8.5%，百济神州涨超4%，药明生物、诺诚健华等均有不同程度上涨。分析人士指出，近期生物医药板块估值修复，加上政策利好推动行业整体重估，预期未来该板块的流动性和基本面可望持续改善。
值得注意的是，港股创新药ETF（159567）今日截至发稿涨2.06%，成交额超2亿元，换手率超11%。此外，该ETF昨日获资金大幅净流入，净流入额超1.6亿元，反映出投资者对生物医药板块的热情。多家券商看好创新药板块前景，认为创新药数据和BD催化有望成为全年主线。在这一背景下，荣昌生物等港股生物医药股受到资金青睐，推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.